areta has a great experience in the production of customized amounts of recombinant proteins using scalable processes that can be adapted to the needs of its customers. areta offers full-service generation of recombinant proteins using mammalian cells and E. Coli host system.

The upstream and downstream process development permits the scale-up of the manufacturing from the laboratory bench through clinical development. Additionally, the purified product can be fully characterized using a full-range of in-house analysis tools.

Process development

The high costs related to the manipulation of complex biologic systems make the optimization of the production processes and the improvement of the yields key factors to the success of a project. areta offers the selection of suitable cell line for the production, the generation of the stable cell line and the selection of high-producing clones.

Moreover, the development includes the choice of the appropriate bioreactor, the scaling up of the culture and the set up of the purification strategy, that are fundamental passages to obtain an effective manufacturing process.